BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 28529132)

  • 1. Efficient, Selective Removal of Human Pluripotent Stem Cells via Ecto-Alkaline Phosphatase-Mediated Aggregation of Synthetic Peptides.
    Kuang Y; Miki K; Parr CJC; Hayashi K; Takei I; Li J; Iwasaki M; Nakagawa M; Yoshida Y; Saito H
    Cell Chem Biol; 2017 Jun; 24(6):685-694.e4. PubMed ID: 28529132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elimination of Teratogenic Human Induced Pluripotent Stem Cells by Bee Venom via Calcium-Calpain Pathway.
    Kim A; Lee SY; Kim BY; Chung SK
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32380745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunologic targeting of CD30 eliminates tumourigenic human pluripotent stem cells, allowing safer clinical application of hiPSC-based cell therapy.
    Sougawa N; Miyagawa S; Fukushima S; Kawamura A; Yokoyama J; Ito E; Harada A; Okimoto K; Mochizuki-Oda N; Saito A; Sawa Y
    Sci Rep; 2018 Feb; 8(1):3726. PubMed ID: 29487310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-Free Transplantation of Patient-Derived Induced Pluripotent Stem Cell Progeny for Customized Islet Regeneration.
    El Khatib MM; Ohmine S; Jacobus EJ; Tonne JM; Morsy SG; Holditch SJ; Schreiber CA; Uetsuka K; Fusaki N; Wigle DA; Terzic A; Kudva YC; Ikeda Y
    Stem Cells Transl Med; 2016 May; 5(5):694-702. PubMed ID: 26987352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethanol extract of Magnoliae cortex (EEMC) limits teratoma formation of pluripotent stem cells by selective elimination of undifferentiated cells through the p53-dependent mitochondrial apoptotic pathway.
    Kim A; Lee SY; Seo CS; Chung SK
    Phytomedicine; 2020 Apr; 69():153198. PubMed ID: 32151917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Ethanol Extract of
    Kim A; Baek SJ; Shin S; Lee SY; Chung SK
    Nutrients; 2023 May; 15(10):. PubMed ID: 37242247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Helping Induced hPSCs Clean Up Their Act.
    Jeong HC; Cha HJ
    Cell Chem Biol; 2017 Jun; 24(6):651-652. PubMed ID: 28644953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient mRNA delivery with graphene oxide-polyethylenimine for generation of footprint-free human induced pluripotent stem cells.
    Choi HY; Lee TJ; Yang GM; Oh J; Won J; Han J; Jeong GJ; Kim J; Kim JH; Kim BS; Cho SG
    J Control Release; 2016 Aug; 235():222-235. PubMed ID: 27266364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation of human foreskin fibroblast-derived induced pluripotent stem cells into hepatocyte-like cells.
    Wang J; Zhao P; Wan Z; Jin X; Cheng Y; Yan T; Qing S; Ding N; Xin S
    Cell Biochem Funct; 2016 Oct; 34(7):475-482. PubMed ID: 27569862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic effects of carboxymethyl-hexanoyl chitosan, cationic polyurethane-short branch PEI in miR122 gene delivery: accelerated differentiation of iPSCs into mature hepatocyte-like cells and improved stem cell therapy in a hepatic failure model.
    Chien Y; Chang YL; Li HY; Larsson M; Wu WW; Chien CS; Wang CY; Chu PY; Chen KH; Lo WL; Chiou SH; Lan YT; Huo TI; Lee SD; Huang PI
    Acta Biomater; 2015 Feb; 13():228-44. PubMed ID: 25463491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient hematopoietic redifferentiation of induced pluripotent stem cells derived from primitive murine bone marrow cells.
    Pfaff N; Lachmann N; Kohlscheen S; Sgodda M; Araúzo-Bravo MJ; Greber B; Kues W; Glage S; Baum C; Niemann H; Schambach A; Cantz T; Moritz T
    Stem Cells Dev; 2012 Mar; 21(5):689-701. PubMed ID: 21732815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural Changes in N-Glycans on Induced Pluripotent Stem Cells Differentiating Toward Cardiomyocytes.
    Kawamura T; Miyagawa S; Fukushima S; Kashiyama N; Kawamura A; Ito E; Saito A; Maeda A; Eguchi H; Toda K; Miyagawa S; Okuyama H; Sawa Y
    Stem Cells Transl Med; 2015 Nov; 4(11):1258-64. PubMed ID: 26378261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation of human pluripotent stem cells to retinal pigmented epithelium in defined conditions using purified extracellular matrix proteins.
    Rowland TJ; Blaschke AJ; Buchholz DE; Hikita ST; Johnson LV; Clegg DO
    J Tissue Eng Regen Med; 2013 Aug; 7(8):642-53. PubMed ID: 22514096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fail-Safe System against Potential Tumorigenicity after Transplantation of iPSC Derivatives.
    Itakura G; Kawabata S; Ando M; Nishiyama Y; Sugai K; Ozaki M; Iida T; Ookubo T; Kojima K; Kashiwagi R; Yasutake K; Nakauchi H; Miyoshi H; Nagoshi N; Kohyama J; Iwanami A; Matsumoto M; Nakamura M; Okano H
    Stem Cell Reports; 2017 Mar; 8(3):673-684. PubMed ID: 28262544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation of primordial germ cells from induced pluripotent stem cells of primary ovarian insufficiency.
    Leng L; Tan Y; Gong F; Hu L; Ouyang Q; Zhao Y; Lu G; Lin G
    Hum Reprod; 2015 Mar; 30(3):737-48. PubMed ID: 25586786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caffeic acid selectively eliminates teratogenic human-induced pluripotent stem cells via apoptotic cell death.
    Kim A; Lee SY; Chung SK
    Phytomedicine; 2022 Jul; 102():154144. PubMed ID: 35537368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expansion and long-term maintenance of induced pluripotent stem cells in stirred suspension bioreactors.
    Shafa M; Sjonnesen K; Yamashita A; Liu S; Michalak M; Kallos MS; Rancourt DE
    J Tissue Eng Regen Med; 2012 Jun; 6(6):462-72. PubMed ID: 21761573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural and Synthetic Materials for Self-Renewal, Long-Term Maintenance, and Differentiation of Induced Pluripotent Stem Cells.
    Dzhoyashvili NA; Shen S; Rochev YA
    Adv Healthc Mater; 2015 Nov; 4(16):2342-59. PubMed ID: 25867178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of transgene-free mouse induced pluripotent stem cells using an excisable lentiviral system.
    Varga E; Nemes C; Davis RP; Ujhelly O; Klincumhom N; Polgar Z; Muenthaisong S; Pirity MK; Dinnyes A
    Exp Cell Res; 2014 Apr; 322(2):335-44. PubMed ID: 24560743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted Integration of Inducible Caspase-9 in Human iPSCs Allows Efficient
    Lipus A; Janosz E; Ackermann M; Hetzel M; Dahlke J; Buchegger T; Wunderlich S; Martin U; Cathomen T; Schambach A; Moritz T; Lachmann N
    Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32260086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.